4//SEC Filing
Fromkin Andrew J. 4
Accession 0001764013-24-000067
CIK 0001764013other
Filed
Apr 3, 8:00 PM ET
Accepted
Apr 4, 4:54 PM ET
Size
7.4 KB
Accession
0001764013-24-000067
Insider Transaction Report
Form 4
Immunovant, Inc.IMVT
Fromkin Drew J
Director
Transactions
- Award
Common Stock
2024-04-02+11,255→ 99,913 total - Award
Stock Option (right to buy)
2024-04-02+4,690→ 4,690 totalExercise: $30.78Exp: 2034-04-02→ Common Stock (4,690 underlying)
Footnotes (2)
- [F1]These restricted stock units ("RSUs") were granted pursuant to the Issuer's 2019 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of common stock upon the vesting of the unit. The RSUs will vest in full on April 2, 2025, subject to the Reporting Person's continuous service to the Issuer as of such date. The Reporting Person may elect to defer settlement of the RSUs upon vesting, subject to the requirements of Rule 409A.
- [F2]The shares underlying the options will vest on April 2, 2025, subject to the Reporting Person's continuous service to the Issuer as of such date.
Documents
Issuer
Immunovant, Inc.
CIK 0001764013
Entity typeother
Related Parties
1- filerCIK 0001341896
Filing Metadata
- Form type
- 4
- Filed
- Apr 3, 8:00 PM ET
- Accepted
- Apr 4, 4:54 PM ET
- Size
- 7.4 KB